Physician profile
Richard A Rosa
NPI 1396739694
$72,758.33
in general payments reported to CMS, 2019-2025
8 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65K · 2020: $58.38 · 2021: $1,965 · 2022: $2,186 · 2023: $74.97 · 2024: $2,926 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,267 · Consulting Fee: $1,132 · Food and Beverage: $759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,267.13 |
| Consulting Fee | $1,131.86 |
| Food and Beverage | $758.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $57,112.40 | 2019-2022 | |
| Wright Medical Technology, INC. | $12,400.00 | 2019 | |
| Restor3d, INC. | $2,939.47 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $173.83 | 2023-2025 | Euflexxa |
| Orthosensor INC. | $58.38 | 2020 | |
| Medline Industries LP | $30.75 | 2024 | |
| Smith+Nephew, INC. | $29.84 | 2021 | |
| Bioventus LLC | $13.66 | 2025 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Rosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.